Hyperlipoproteinemia Type V

A severe type of hyperlipidemia, sometimes familial, that is characterized by the elevation of both plasma CHYLOMICRONS and TRIGLYCERIDES contained in VERY-LOW-DENSITY LIPOPROTEINS. Type V hyperlipoproteinemia is often associated with DIABETES MELLITUS and is not caused by reduced LIPOPROTEIN LIPASE activity as in HYPERLIPOPROTEINEMIA TYPE I .

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Xanthomatosis (Xanthoma)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Hyperlipoproteinemia Type V:

1.	Apolipoprotein E4IBA 10/23/1982 - "Hyperlipoproteinemia type V and apolipoprotein E4."

Therapies and Procedures

1.	Hemoperfusion 11/01/1986 - "[Use of entero-and hemosorption in a patients with diabetic xanthomatosis and hyperlipoproteinemia type V]."
2.	Amputation 03/01/1982 - "Extremity amputation following radial artery cannulation in a patient with hyperlipoproteinemia type V."